Only one of four patients persisted with Novo Nordisk's (NVO) newer GLP-1 drugs, Wegovy or Ozempic, two years after ...
An older drug in the same GLP-1 class as Ozempic, Wegovy, Mounjaro and Zepbound appeared to protect the brain from shrinking ...
Researchers from Monell Chemical Senses Center have identified a specific population of neurons in the brain that could be ...
Who should receive Ozempic and GLP-1 drugs given their high demand and limited supply? Experts debate prioritizing those with ...
A weight loss drug similar to Ozempic appeared to slow cognitive decline in patients with mild Alzheimer’s disease, new ...
Noom, Calibrate, and Embla tell customers they can stop taking GLP-1s and keep off the weight they’ve lost. Doctors and drug manufacturers disagree.
The next wave of obesity drugs could help people lose even more weight—and make some pharma companies a fortune.
An Alzheimer’s study reported liraglutide appeared to slow cognitive decline compared to a placebo. Researchers plan more testing to confirm.
Share on Pinterest GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound can affect people differently. BONNINSTUDIO/Stocksy United Misconceptions about the benefits and risks of GLP-1 drugs ...
Research shows the drug can cut the risk of serious cardiovascular issues like heart attack and stroke in certain patients.
Research has proposed that Ozempic may ease alcohol addiction as well. The injectable drug — which mimics the GLP-1 hormone the body produces after eating, so users feel fuller for longer — has ...